[Clinical investigation of homoharringtonine in combination with all-transretinoic acid and arsenic trioxide for acute promyelocytic leukemia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 34, Issue 2, 2013, Pages 144-148

  Pei, Ren zhi ^a   Li, Shuang yue ^b   Zhang, Pei sheng ^b   Ma, Jun xia ^b   Liu, Xu hui ^b   Du, Xiao hong ^b   Chen, Dong ^b   Sha, Ke ya ^b   Chen, Lie guang ^b   Cao, Jun jie ^b   Zhuang, Xian xu ^b   Wu, Jing yi ^b   Lin, L ^b   Fan, Zheng ^b   Ye, Pei pei ^b   Tang, Shan hao ^b   Zhang, Bi bo ^b   Shi, Xiao wei ^b  

^a Yinzhou People's Hospital   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; HARRINGTONINE DERIVATIVE; HOMOHARRINGTONINE; ORGANOARSENIC DERIVATIVE; OXIDE; RETINOIC ACID;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; FEMALE; HARRINGTONINES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OXIDES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRETINOIN;

EID: 84887131224     PISSN: 02532727     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)